CellCarta
Kristien Verhoeven is an accomplished executive with extensive experience in the clinical research and biotechnology sectors, currently serving as SVP and Global Business Unit Lead for Histopathology, Genomics, and Logistics at CellCarta since July 2021. Verhoeven has a strong track record in P&L management, achieving over 20% year-over-year revenue and EBITDA growth across multiple global sites. Previously, Verhoeven held the position of Chief Operating Officer at HistoGeneX, overseeing operational growth and integrating acquisitions. With a Ph.D. in Medical Sciences from the University of Antwerp and an MBA from the Antwerp Management School, Verhoeven combines scientific expertise with business acumen, driving value creation through operational efficiency, automation, and customer focus throughout a career that includes significant roles at Cochlear and VIB.
This person is not in any offices
CellCarta
CellCarta's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integratedImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.